AIMS AND SCOPE
The European Journal of Human Health is published in accordance with the principles of independent, unbiased, and double-blinded peer review. The European Journal of Human Health accepts invited review articles, research articles, short reports, case reports, letters to the editor and images within the scope of medicine, provided that they have not been published elsewhere before. Basic science manuscripts, such as randomized, cohort, cross-sectional, and case control studies, are given preference. All manuscripts are subject to editorial revision to ensure they conform to the style adopted by the journal.
The editorial and publication process of the European Journal of Human Health are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.
The journal should be abbreviated as “Eur J Hum Health” when referenced.
Publishing Fee
European Journal of Human Health is an open access journal. The European Journal of Human Health does not charge any fee for article submission or processing. Also manuscript writers are not paid by any means for their manuscripts.
Article Submission
The journal evaluates only the manuscripts submitted through its online submission system on the web site https://ejhh.net/. Manuscripts sent by other means will not be accepted.
The primary conditions for the acceptance of manuscripts for publication are originality, scientific value and citation potential.
Publication Language
The publication language of the European Journal of Human Health is English.
Editorial Process
Following receiving of each manuscript, a checklist is completed by the Editorial Assistant. The Editorial Assistant checks that each manuscript contains all required components and adheres to the author guidelines, after which time it will be forwarded to the Editor in Chief. Following the Editor in Chief's evaluation, each manuscript is forwarded to the Associate Editor, who in turn assigns reviewers. Generally, all manuscripts will be reviewed by at least two reviewers selected by the Associate Editor, based on their relevant expertise. Associate editor could be assigned as a reviewer along with the reviewers. After the reviewing process, all manuscripts are evaluated in the Editorial Board Meeting.
The European Journal of Human Health's editor and Editorial Board members are active researchers. It is possible that they would desire to submit their manuscript to the European Journal of Human Health. This may be creating a conflict of interest. These manuscripts will not be evaluated by the submitting editor(s). The review process will be managed and decisions made by editor-in-chief who will act independently. In some situation, this process will be overseen by an outside independent expert in reviewing submissions from editors.
Policy on Artificial Intelligence Usage
In our pursuit of scholarly excellence, this policy outlines the principled use of artificial intelligence (AI) in our journal. Authors employing AI tools must transparently disclose their methods, ensuring ethical conduct and full accountability. This policy underscores the importance of transparency, responsible authorship, and the prohibition of AI-generated content as primary sources. Through these guidelines, we maintain the integrity of our academic contributions while embracing the evolving landscape of AI technology.
1. Authorship and AI: Authors utilizing AI tools in manuscript writing, image/graphical element production, or data collection and analysis must transparently disclose the specifics of AI tool usage in the Materials and Methods (or equivalent) section of the paper. This disclosure should include details on how the AI tool was employed and which specific tool was utilized. Authors retain full responsibility for the content of their manuscript, even sections generated by an AI tool, and are accountable for any violations of publication ethics. Authors must confirm the absence of plagiarism in text or images produced by AI, ensuring proper attribution and full citations for all quoted material.
2. Transparency in AI Usage: Authors are required to openly acknowledge the use of AI tools in their submissions, detailing their role in manuscript creation, image/graphical element production, or data analysis. Authors are liable for any potential ethical breaches, including plagiarism, in materials generated by AI assistance.
“AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.” COPE Position Statement on Authorship and AI tools. Detailed information about the statement can be accessed at https://publicationethics.org/cope-position-statements/ai-author
After reviewing the COPE statement, the editors of the European Journal of Human Health have decided that papers should include a statement in a section called “Declaration Regarding the Use of AI and AI-Assisted Technologies” to let readers know if AI or AI-assisted tools were used in the writing process. It's important to remember that all authors are responsible for the content of their work. This declaration does not apply to the use of basic tools for checking grammar, spelling, or references (such as Mendeley, EndNote, Zotero, and others). If there is nothing to declare, there is no need to add a statement.
It is suggested that authors follow this format when preparing their statement:
During the preparation of this work, the author(s) utilized [NAME OF TOOL(S) USED] to [DESCRIPTION OF HOW THE TOOL(S) WERE UTILIZED AND HOW THE VALIDITY OF THE OUTPUTS WAS EVALUATED]. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted [SPECIFY WHICH ASPECTS OF THE STUDY, ARTICLE CONTENTS, DATA, OR SUPPORTING FILES WERE AFFECTED/GENERATED].
Example:
During the preparation of this work, the author(s) utilized OpenAI's ChatGPT to generate summaries of research articles related to the topic. These summaries were evaluated by comparing them to manually written summaries by experts in the field. Upon confirming the accuracy and relevance of the generated summaries, they were integrated into the literature review section of the manuscript. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted the efficiency of literature review process and the comprehensiveness of the gathered research insights.
3. Editorial Transparency: Editors incorporating AI tools in the manuscript evaluation process must maintain transparency in their approach. The utilization of AI should be clearly stated by the editorial board to uphold the integrity of the peer-review process.
4. Citation of AI-Generated Material: Citation of AI-generated material as a primary source is not permissible in our journal. Authors must rely on human-generated content for primary sources, ensuring the credibility and integrity of the research presented. By adhering to these guidelines, our journal aims to ensure the responsible and transparent integration of artificial intelligence, upholding the highest standards of academic integrity and scholarly rigor in our publications.
STATEMENTS AND GUIDELINES
All statements and opinions expressed in the manuscripts published in European Journal of Human Health reflect the views of the author(s). All liability for the advertisements rests with the appropriate organization(s). The Editor-in-Chief does not accept any responsibility for articles and advertisements.
The manuscripts submitted to the journal, except abstracts, presentations, reviews and parts of theses, should not have been accepted and published previously elsewhere in electronic or printed format. Manuscripts evaluated and rejected by other journals must mention any previous submissions and supply reviewer’s reports. This will help to accelerate the evaluation process. If the submitted manuscript has been previously presented at a meeting, the name, date, city and country must be specified.
The authors transfer all copyrights of the manuscript in the framework of national and international regulations to the European Journal of Human Health as of evaluation process. A Copyright Transfer Form signed by corresponding author in order must be submitted to the journal with manuscript. Authors must confirm that they will not submit the work to another journal, publish it in the original or another language and or allow a third party to use the manuscript without the written permission of the European Journal of Human Health.
All contents are the authors’ responsibility. All financial liability and legal responsibility associated with the copyright of submitted tables, figures and other visual materials protected by national and international laws rest with the authors. The authors take responsibility for any legal proceedings issued against the journal.
Rejected manuscripts will not be returned except for artwork.
To clarify scientific contributions and responsibilities and any conflict of interest issues relevant to the manuscript, all parts of the ‘Authors' Contribution’ form must be completed by the corresponding author and the‘ICMJE Uniform Disclosure Form for Potential Conflicts of Interest’must be completed online by all authors. Both forms should be included in the manuscript at the time of original submission.
Ethics
When reporting experiments conducted with humans indicate that the procedures were in accordance with ethical standards set forth by the committee that oversees human experimentation. The authors should acknowledge and provide detailed information on any contributions in kind and financial support given by any foundations, institutions and firms before references section.
Approval of research protocols by the relevant Institutional Review Board (IRB) or Ethics Commitee, in accordance with international agreements ("WMA Declaration of Helsinki", "Guide for the Care and use of Laboratory Animals"), is required for all experimental, clinical, and drug studies. Studies performed on human require IRB or Ethics Commitee certificate including approval number. It also should be indicated in the “Materials and Methods” section. Patient names, initials, and hospital identification numbers should not be used. Manuscripts reporting the results of experimental investigations conducted with humans must state that the study protocol received institutional review board approval and that the participants provided informed consent. Non-compliance with scientific accuracy is not in accord with scientific ethics. Authors may be asked by the Editor-in-Chief’s Office for an ethics committee report or similar in other circumstances also. Manuscripts reporting the results of experimental studies must explain in detail all procedures which volunteer subjects and patients have undergone and a statement indicating that consent for the study has been obtained from all subjects should be included in the text. Animal studies should clearly specify how pain or discomfort has been relieved. We will be unable to accept research papers without this statement.
Plagiarism: To re-publish whole or in part the contents of another author's publication as one's own without providing a reference. Fabrication: To publish data and findings/results that do not exist.
Duplication: Use of data from another publication, which includes re-publishing a manuscript in different languages.
Salamisation: To create more than one publication by dividing the results of a study preternaturally. We disapproval upon such unethical practices as plagiarism, fabrication, duplication, and salamisation, as well as efforts to influence the review process with such practices as gifting authorship, inappropriate acknowledgements, and references. Additionally, authors must respect participant right to privacy. On the other hand, short abstracts published in congress books that do not exceed 400 words and present data of preliminary research, and those that are presented in an electronic environment are not accepted pre-published work. Authors in such situation must declare this status on the first page of the manuscript and in the cover letter (The COPE flowchart is available at: http://publicationethics.org).
We use iThenticate to screen all submissions for plagiarism before publication.
Conditions of Publication
All authors are required to affirm the following statements before their manuscript is considered:
1. The manuscript is being submitted only to The European Journal of Human Health
2. The manuscript will not be submitted elsewhere while under consideration by The European Journal of Human Health
3. The manuscript has not been published elsewhere, and should it be published in the European Journal of Human Health it will not be published elsewhere without the permission of the editors (these restrictions do not apply to abstracts or to press reports for presentations at scientific meetings)
4. All authors are responsible for the manuscript's content
5. All authors participated in the study concept and design, analysis and interpretation of the data, drafting or revising of the manuscript, and have approved the manuscript as submitted. In addition, all authors are required to disclose any professional affiliation, financial agreement, or other involvement with any company whose product figures prominently in the submitted manuscript. Authors of accepted manuscripts will receive electronic page proofs and are responsible for proofreading and checking the entire article within two days. Failure to return the proof in two days will delay publication. If the authors cannot be reached by email or telephone within two weeks, the manuscript will be rejected and will not be published in the journal.
Copyright
The authors must obtain the permission of the copyright holder for non-original tables, figures, graphs, images and other visuals.
All accepted manuscripts become the permanent property of the European Journal of Human Health and may not be published elsewhere in whole or in part ¾ without written permission. If article content is copied or downloaded for non-commercial research and education purposes, a link to the appropriate citation [authors, journal, article title, volume, issue, page numbers, digital object identifier (DOI)] and the link to the definitive published version should be maintained. Copyright notices and disclaimers must not be deleted.
PREPARATION AND SUBMISSION OF MANUSCRIPTS
Manuscripts should be concise and clear.
Manuscript files should be prepared with Microsoft Office Word.
Please format your manuscript as follows:
Use Times New Roman style, 12 punto, justified and double line spacing throughout (including reference list and figure legends).
Leave 2 cm space from each edge of pages.
Number all pages in the bottom-right hand corner, but do not use numbers for headings and /or subheadings.
Define all abbreviations when first mentioned.
Do not mention names and/or institutions of the authors within the main text except title page.
The online submission system will direct authors during all stages of submission and provide necessary support for accelerating the submission process. A list of the files that should be supplied through the online submission system is provided below.
Manuscripts should be prepared according to ICMJE guidelines (http://www.icmje.org).
Original manuscripts require a structured abstract. Label each section of the structured abstract with the appropriate subheading (Objective, Materials and Methods, Results, and Conclusion). Case reports require short unstructured abstracts. Letters to the editor do not require an abstract. Research or project support should be acknowledged as a footnote on the title page.
Technical and other assistance should be provided on the title page.
Title Page
Information about the authors and their institutions should not be included in the main text, tables, figures and video documents. Since submitted manuscripts are evaluated by the reviewers through the online system, personal identification is excluded in the interests of unbiased interpretation.
Thus, only information about the manuscript as specified below should be included on the title page. For each type of manuscript, it is mandatory to upload a title page as a separate Microsoft Word document through the online submission system.
Title: The title should provide important information regarding the manuscript's content. The title page should include the authors' names, degrees, and institutional/professional affiliations, a short title, abbreviations, keywords, financial disclosure statement, conflict of interest statement, and acknowledgments. If a manuscript includes authors from more than one institution, each author's name should be followed by a superscript number that corresponds to their institution, which is listed separately. The correspondence address should contain the full name of the corresponding author, postal and e-mail addresses, phone and fax numbers. If the content of the manuscript has been presented before, the name, date and place of the meeting must be noted.
Running Head: The running head should not be more than 40 characters, including spaces, and should be located at the bottom of the title page.
Word Count: A word count for the manuscript, excluding abstract, acknowledgments, figure and table legends, and references, should be provided not exceed 3000 words. The word count for an abstract should be not exceed 250 words.
Conflict of Interest Statement: To prevent potential conflicts of interest from being overlooked, this statement must be included in each manuscript. In case there are conflicts of interest, every author should complete the ICMJE general declaration form, which can be obtained at: http://www.icmje.org/coi_disclosure.pdf
Abstract and Keywords: The second page should include an abstract that does not exceed 250 words. As most readers read the abstract first, it is critically important. Moreover, as various electronic databases integrate only abstracts into their index, important findings should be presented in the abstract.
Abstract
Objective: The abstract should state the objective (the purpose of the study and hypothesis) and summarize the rationale for the study.
Materials and Methods: Important methods should be written respectively.
Results: Important findings and results should be provided here.
Conclusion: The study's new and important findings should be highlighted and interpreted.
The manuscripts submitted to our journal are classified and evaluated according to the manuscript types stated below. Provide at least 3-5 keywords below the abstract to assist indexers. During preliminary evaluation, the editors assess whether a manuscript’s format and sub-headings are prepared in accordance with the journal’s guidelines. Therefore, it is important that authors check the accuracy of the main text in terms of the following. Manuscripts should also be prepared according to STROBE criteria for observational studies, STARD criteria for accuracy studies of diagnosis, CONSORT (http://www.consort-statement.org) criteria for randomized controlled trials. After keywords in original research articles there must be a paragraph defining “What is known on the subject and what does the study add”.
MANUSCRIPT TYPES
Original Research
Title
Structured Abstract: It should be structured with Objective, Methods, Results and Conclusion subheadings.
Keywords: This section should contain a minimum of three and a maximum of six items in accordance with Medical Subject Headings (MeSH) terms prepared by the National Library of Medicine (NLM) and should be placed just below the abstract.
Abstract length: Not to exceed 250 words. “What is known on the subject and what dos the study add” not exceed 100 words.
Article length: Not to exceed 5000 words.
Main Text: It should consist of Introduction, Methods, Results, Discussion, Limitations of the Study and Conclusion sections and should not exceed 5000 words excluding the references.
Original researches should have the following sections;
Introduction: The introduction should include an overview of the relevant literature presented in summary form (one page), and whatever remains interesting, unique, problematic, relevant, or unknown about the topic must be specified. The introduction should conclude with the rationale for the study, its design, and its objective(s).
Materials and Methods: Clearly describe the selection of observational or experimental participants, such as patients, laboratory animals, and controls, including inclusion and exclusion criteria and a description of the source population. Identify the methods and procedures in sufficient detail to allow other researchers to reproduce your results. Provide references to established methods (including statistical methods), provide references to brief modified methods, and provide the rationale for using them and an evaluation of their limitations. Identify all drugs and chemicals used, including generic names, doses, and routes of administration. The section should include only information that was available at the time the plan or protocol for the study was devised on STROBE (http://www.strobe-statement.org).
Statistics: Describe the statistical methods used in enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Statistically important data should be given in the text, tables and figures. Provide details about randomization, describe treatment complications, provide the number of observations, and specify all computer programs used.
Results: Present your results in logical sequence in the text, tables, and figures. Do not present all the data provided in the tables and/or figures in the text; emphasize and/or summarize only important findings, results, and observations in the text. For clinical studies provide the number of samples, cases, and controls included in the study. Discrepancies between the planned number and obtained number of participants should be explained. Comparisons, and statistically important values (i.e. p value and confidence interval) should be provided.
Discussion: This section should include a discussion of the data. New and important findings/results, and the conclusions they lead to should be emphasized. Link the conclusions with the goals of the study, but avoid unqualified statements and conclusions not completely supported by the data. Do not repeat the findings/results in detail; important findings/results should be compared with those of similar studies in the literature, along with a summarization. In other words, similarities or differences in the obtained findings/results with those previously reported should be discussed.
Study Limitations: Limitations of the study should be detailed. In addition, an evaluation of the implications of the obtained findings/results for future research should be outlined.
Conclusion: The conclusion of the study should be highlighted.
References:
Cite references in the text, tables, and figures with numbers in parentheses. Number references consecutively according to the order in which they first appear in the text. Journal titles should be abbreviated according to the style used in Index Medicus (consult List of Journals Indexed in Index Medicus). The references are written in APA style. Include among the references any paper accepted, but not yet published, designating the journal and followed by, in press. Authors are solely responsible for the accuracy of all references.
The number of references is limited to 5 for Letter to the Editor and Brief Report, 15 for Case Report, 50 for Original Article, and 100 for Review.
Examples of References:
1. Ghoneim, I. A., Miocinovic, R., Stephenson, A. J., Garcia, J. A., Gong, M. C., Campbell, S. C., Hansel, D. E., & Fergany, A. F. (2011). Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology, 77(4), 867–870. https://doi.org/10.1016/j.urology.2010.08.066
2. Yaycioglu, O., Eskicorapci, S., Karabulut, E., Soyupak, B., Gogus, C., Divrik, T., Turkeri, L., Yazici, S., & Ozen, H. (2013). A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer. Japanese Journal of Clinical Oncology, 43(1), 63–68.
3. Wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. W., & Peters, C. A. (2012). Campbell-Walsh urology (10th ed.). Elsevier & Saunders.
4. Pearle, M. S., & Lotan, Y. (2012). Urinary lithiasis: Etiology, epidemiology, and pathogenesis. In A. J. Wein, L. R. Kavoussi, A. C. Novick, A. W. Partin, & C. A. Peters (Eds.), Campbell-Walsh urology (10th ed., pp. 1257–1323). Elsevier & Saunders.
5. Nguyen, C. T., Fu, A. Z., Gilligan, T. D., Kattan, M. W., Wells, B. J., & Klein, E. A. (2008). Decision analysis model for clinical stage I nonseminomatous germ cell testicular cancer. The Journal of Urology, 179, 495a. (Abstract)
6. Lingeman, J. E. (2011). Holmium laser enucleation of the prostate—If not now, when? The Journal of Urology, 186(5), 1762–1763. (Letter to the Editor)
7. Fine, M. S., Smith, K. M., Shrivastava, D., Cook, M. E., & Shukla, A. R. (2011). Posterior urethral valve treatments and outcomes in children receiving kidney transplants. The Journal of Urology, 185(Suppl), 2491–2496.
8. Diabetes Australia. (2015). Gestational diabetes [Internet]. Canberra (AU): Diabetes Australia. Retrieved November 23, 2017, from https://www.diabetesaustralia.com.au/gestational-diabetes
Case Reports
Since a limited number of case reports is published, only reports which are related to rare cases and conditions that constitute challenges in diagnosis and treatment, offer new methods or suggest knowledge not included in books, and are interesting and educational are accepted for publication.
Title
Abstract length: Not to exceed 100 words.
Article length: Not to exceed 1000 words. Case Reports can include maximum 1 figure and 1 table or 2 figures or 2 tables.
Case reports should be structured as follows:
Abstract: An unstructured abstract that summarizes the case.
Keywords: Not included.
Introduction: A brief introduction (recommended length: 1-2 paragraphs).
Case Presentation: This section describes the case in detail, including the initial diagnosis and outcome.
Discussion: This section should include a brief review of the relevant literature and how the presented case furthers our understanding to the disease process.
References: The reference list should follow the main text and the number of references should be limited to 10.
Review Articles
Abstract length: Not to exceed 250 words.
Article length: Not to exceed 4000 words.
Review articles should not include more than 100 references. Reviews should include a conclusion, in which a new hypothesis or study about the subject may be posited. Do not publish methods for literature search or level of evidence. Authors who will prepare review articles should already have published research articles on the relevant subject. There should be a maximum of two authors for review articles.
Preparation of Manuscripts
The “European Journal of Human Health’’ follows the Recommendations for “the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” (International Committee of Medical Journal Editors - http://www.icmje.org/). Upon submission of the manuscript, authors are to indicate the type of trial/research and provide the checklist of the following guidelines when appropriate:
CONSORT statement for randomized controlled trials (Moher D, Schultz KF, Altman D, for the CONSORT Group. The CONSORT statement revised recommendations for improving the quality of reports of parallel group randomized trials. JAMA 2001; 285: 1987-91) (http://www.consort-statement.org/),
PRISMA for preferred reporting items for systematic reviews and meta-analyses (Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6(7): e1000097.) (http://www.prisma-statement.org/),
STARD checklist for the reporting of studies of diagnostic accuracy (Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al, for the STARD Group. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 2003;138:40-4.) (http://www.stard-statement.org/),
STROBE statement-checklist of items that should be included in reports of observational studies (http://www.strobe-statement.org/),
MOOSE guidelines for meta-analysis and systemic reviews of observational studies (Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis of observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12).
CARE guidelines are designed to increase the accuracy, transparency, and usefulness of case reports. (Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; the CARE Group. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development.) (http://www.care-statement.org/)
Clinical Trial Policy
All clinical trials, which are any research projects that prospectively assign individuals or a group of people to an intervention, with or without concurrent comparison or control groups, in order to study the relationship between a health-related intervention and a health outcome, must be registered in a public trials registry acceptable to the International Committee of Medical Journals Editors (ICMJE). Authors of randomized controlled trials must adhere to the CONSORT guidelines , and provide both a CONSORT checklist (for protocols, see the SPIRIT guidance) and flow diagram. We require that you choose the MS Word template at www.consort-statement.org for the flow chart and cite/upload it in the manuscript as a figure. Submitted manuscripts must include the unique registration number in the Abstract as evidence of registration.
You can register for clinical trials by visiting the following link:
https://clinicaltrials.gov/
To register the relevant record in the system and learn more about the protocol to be followed, please review the link below:
https://classic.clinicaltrials.gov/ct2/manage-recs/how-register
Letters to the Editor
Letters to the Editor aim to discuss the importance of a manuscript previously published in the journal. This type of manuscripts should also include a comment on the published manuscript. Moreover, articles on topics of interest to readers within the scope of the journal, especially on educational issues, can be published in the format of a Letter to the Editor.
Article length: Not to exceed 500 words. Letters can include no more than 500 words of text, 5-10 references, and 1 figure or table. No abstract is required, but please include a brief title.
From the Editor
Articles on topics of interest to readers within the scope of the journal, especially on educational issues, can be published in the format of a Editorial.
Title
Main Text: It should not include subheadings and it should be limited to 500 words.
References: The reference list should follow the main text and the number of references should be limited to five. The volume, year, issue, page numbers, authors’ names and title of the manuscript should be clearly stated, included in the list of references and cited within the text.
Abstract and keywords are not included.
Brief Reports
Brief reports represent new developments or original incomplet studies. Brief reports include an abstract (no more than 100 words) and are limited to no more than 1500 words of text, a total of 2 inserts (tables or figures), 15 references.
Tables, Graphics, Figures, and Images Tables: Supply each table on a separate file. Number tables according to the order in which they appear in the text, and supply a brief caption for each. Give each column a short or abbreviated heading. Write explanatory statistical measures of variation, such as standard deviation or standard error of mean. Be sure that each table is cited in the text.
Figures: Figures should be professionally drawn and/or photographed. Authors should number figures according to the order in which they appear in the text. Figures include graphs, charts, photographs, and illustrations. Each figure should be accompanied by a legend that does not exceed 50 words. Use abbreviations only if they have been introduced in the text. Authors are also required to provide the level of magnification for histological slides. Explain the internal scale and identify the staining method used. Figures should be inserted at the end of the references in the main text. High-resolution image files are not preferred for initial submission as the file sizes may be too large.
Statistical Analysis:
Statistical analysis should be conducted in accordance with the guidelines on reporting statistical data in medical journals.
The software used for statistical analysis must be described. Data must be expressed as mean ± standard deviation when parametric tests are used to compare continuous variables. For non-parametric tests, data must be expressed as median (minimum-maximum) or percentiles (25th and 75th percentiles). In advanced and complex statistical analyses, relative risk (RR), odds ratio (OR) and hazard ratio (HR) must be supported by confidence intervals and p values.
The outcomes of statistical analyses and interpretation of the results must be in evidence-based scientific language.
Authorship: Each author should have participated sufficiently in the work to assume public responsibility for the content. Any portion of a manuscript that is critical to its main conclusions must be the responsibility of at least 1 author.
Contributor's Statement: All submissions should contain a contributor's statement page. Each manuscript should contain substantial contributions to idea and design, acquisition of data, or analysis and interpretation of findings. All persons designated as an author should qualify for authorship, and all those that qualify should be listed. Each author should have participated sufficiently in the work to take responsibility for appropriate portions of the text.
Acknowledgments: Acknowledge support received from individuals, organizations, grants, corporations, and any other source. For work involving a biomedical product or potential product partially or wholly supported by corporate funding, a note stating, "This study was financially supported (in part) with funds provided by (company name) to (authors' initials)", must be included. Grant support, if received, needs to be stated and the specific granting institutions' names and grant numbers provided when applicable. Authors are expected to disclose on the title page any commercial or other associations that might pose a conflict of interest in connection with the submitted manuscript. All funding sources that supported the work and the institutional and/or corporate affiliations of the authors should be acknowledged on the title page.
SPECIAL TERMS AND CONDIDITION
For double-blinded peer-review process, the names of the corresponding author and other authors, their affiliations and any information on the study centres should not be included in any part of the submitted manuscripts and images, except the Title Page. This information should be added to the relevant section of the online submission system and included in the Title Page.
Pharmaceutical products should be written with their generic names and brand and company names, city and country should be specified for medical equipment and devices.
Tables, Graphs and Figures
Tables, Graphs, Figures and other visuals should be numbered in the order of their citation within the text and names of patients, doctors and institutions should not be disclosed.
Tables should be prepared in a Microsoft Office Word document using the command ‘Insert Table’ and inserted at the end of the references in the main text.
Tables should not be submitted in JPEG, TIFF or other visual formats. For microscopic images, the magnification ratio and staining technique used should be specified in addition to figure legends.
All visuals should have a high resolution (minimum 300 dpi).
The thickness of the lines in graphs should be sufficient to minimize loss of quality if size reduction is needed during the printing process. The width of the graphs should be 9 cm or 18 cm. Drawings should be performed by professionals. No grey colours should be used.
Abbreviations should be explained in alphabetical order at the bottom of the tables, graphs and figures
• Punctuation symbols should be used as *,†,‡,§,II,¶,**,††,‡‡ in an order.
• Roman numbers should be avoided in tables and figures within the text and their titles.
• Decimal numbers used in text, tables and figures should be separated by dots.
• Tables should be easily understandable and should not repeat the data in the main text.
• In addition to the pictures included in case reports and original images, video and movie images are published on the journal’s website. These images should be prepared in MPEG format with a maximum size of 2 MB. They should be submitted to the journal with the manuscript documents. The names of patients, doctors, institutions and places should be omitted from all documents.
CHECK LIST
• The authors must obtain the permission of the copyright holder for non-original tables, figures, graphs, images and other visuals.
• Ethic committee approval must be obtained for all original articles.
Preparation of manuscripts
• Use Times New Roman style, 12 punto, justified and double line spacing throughout (including reference list and figure legends).
• Leave 2 cm space from each edge of pages.
• Number all pages in the bottom-righthand corner, but do not use numbers for headings and /or subheadings.
• Define all abbreviations when first mentioned.
• Decimal numbers used in text, tables and figures should be separated by dots.
• Do not mention names and/or institutions of the authors within the main text except title page.
• Structured abstract should be structured with Objective, Methods, Results and Conclusion subheadings and should be limited to 250 words.
• Each keyword accordance with Medical Subject Headings (MeSH) terms prepared by the National Library of Medicine (NLM) and should be placed just below the abstract.
• Reference numbers should be written between curved brackets at where they are cited in the text.
• For references with six and fewer authors, all authors should be listed. For references with more than six authors, the first six authors should be listed, followed by ‘et al’.
• Tables should be prepared in a Microsoft Office Word document using the command ‘Insert Table’ and inserted at the end of the references in the main text.
• Figures should be inserted at the end of the references in the main text.
• Punctuation symbols should be used as *,†,‡,§,II,¶,**,††,‡‡ in an order.
OPEN ACCESS AND COMMONS USER LICENSES
Open Access
European Journal of Human Health is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
Commons User Licenses
By publishing in this Journal, the Authors and Co-Authors agree to transfer all the Copyright of the article to European Journal of Human Health. The authors should acknowledge that the use of data, tables, figures, or videos (except for lecture) published in European Journal of Human Health without written permission of the copyright holder is plagiarism, even if authors use them for their own papers. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
The Review Process Each manuscript submitted to the European Journal of Human Health is subject to an initial review by the editorial office in order to determine if it is aligned with the journal's aims and scope, and complies with essential requirements. Manuscripts sent for peer review will be assigned to one of the journal's associate editors that has expertise relevant to the manuscript's content. All manuscripts are double-blind peer reviewed. All accepted manuscripts are sent to a statistical and English language editor before publishing. Once papers have been reviewed, the reviewers' comments are sent to the Editor, who will then make a preliminary decision on the paper. At this stage, based on the feedback from reviewers, manuscripts can be accepted, rejected, or revisions can be recommended. Following initial peer-review, articles judged worthy of further consideration often require revision. Revised manuscripts generally must be received within 3 months of the date of the initial decision. Extensions must be requested from the Associate Editor at least 2 weeks before the 3-month revision deadline expires; the European Journal of Human Health will reject manuscripts that are not received within the 3-month revision deadline. Manuscripts with extensive revision recommendations will be sent for further review (usually by the same reviewers) upon their re-submission. When a manuscript is finally accepted for publication, the Technical Editor undertakes a final edit and a marked-up copy will be e-mailed to the corresponding author for review and to make any final adjustments.
Abbreviations and Symbols Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for an abbreviation should precede its first use in the text, unless it is a standard abbreviation. All acronyms used in the text should be expanded at first mention, followed by the abbreviation in parentheses; thereafter the acronym only should appear in the text. Acronyms may be used in the abstract if they occur 3 or more times therein but must be reintroduced in the body of the text. Generally, abbreviations should be limited to those defined in the AMA Manual of Style, current edition. A list of each abbreviation (and the corresponding full term) used in the manuscript must be provided on the title page.
Online Article Submission Process The European Journal of Human Health uses submission software powered by Online Article Submission articles the website for submissions to the European Journal of Human Health is https://ejhh.net/dergi.jsp This system is quick and convenient, both for authors and reviewers.
The ORCID (Open Researcher and Contributor ID) number of the correspondence author should be provided while sending the manuscript. A free registration can create at http://orcid.org.